From MVP to Market: Scaling Palm Vein Technology with BioWavePass

Palm vein technology is moving rapidly from proof-of-concept projects towards real-world commercial applications.

For technology partners, successfully demonstrating palm vein recognition with a small number of users is only the beginning. The next challenge is proving that the solution can perform effectively when a project moves from an MVP to tens of thousands of users and beyond.

To help our strategic partners make that transition, BioWavePass is introducing a dedicated Large-Scale Palm Vein Algorithm Support Program.

50,000–100,000 User IDs, Free for 3 Months

Qualified BioWavePass partners can receive a 50,000 to 100,000 User ID large-scale algorithm license free for three months.

This program is designed specifically for partners who have already progressed beyond initial evaluation and are developing a genuine MVP with the potential for commercial deployment.

The objective is simple: give our partners the opportunity to test palm vein technology at a realistic scale before making the final investment in large-scale licensing.

Private Server Deployment for Palm Vein Technology

For approved projects, the BioWavePass technical team will support deployment of the large-scale palm vein algorithm directly to the partner’s private server environment.

This enables development teams to evaluate important aspects of their solution within their own infrastructure, including:

• Large-scale palm vein identification
• Recognition performance
• Database and server architecture
• System integration
• User enrolment and matching workflows
• Performance under realistic project conditions

Instead of relying only on small-scale testing, partners can validate how their complete palm vein technology solution performs in an environment much closer to commercial deployment.

Supporting Real-World Palm Vein Technology Applications

Palm vein technology provides contactless biometric authentication by identifying the unique vein patterns beneath a user’s skin.

This creates opportunities across a growing range of applications, including:

• Palm payment
• Banking and financial authentication
• Digital identity
• Customer verification
• Membership and loyalty programs
• Self-service terminals
• Large-scale biometric identification

Our focus is not simply on supplying palm vein readers. BioWavePass aims to provide the hardware, algorithms, SDK and technical support required to help partners develop complete palm vein technology solutions.

What Happens After the 3-Month Trial?

There is no requirement to purchase the large-scale license simply because the evaluation period has ended.

Partners can review the results of their MVP, evaluate the performance of the palm vein technology within their own application, and decide whether the project is ready to move forward.

For successful projects proceeding to commercial deployment, the appropriate large-scale algorithm package can be purchased with a one-time license fee for lifetime usage.

This gives partners greater predictability when calculating the long-term commercial model for their solution.

Who Can Join the Program?

Deploying and supporting large-scale palm vein technology requires dedicated engineering and technical resources. For this reason, the free license program is reserved for partners actively investing in the development of a commercial palm vein solution.

Partners should:

• Have signed a Strategic Partnership Agreement or Exclusive Partnership Agreement
• Have progressed to a genuine MVP testing stage
• Place an initial MVP testing order of at least 100 palm vein devices

By focusing the program on committed projects, our technical team can provide more meaningful support throughout the MVP, integration and validation process.

From Palm Vein Technology MVP to Commercial Scale

A successful palm vein project should not stop when the first prototype works.

The real opportunity comes when palm vein technology moves beyond the demonstration stage and becomes a solution capable of supporting 50,000, 100,000 or potentially millions of users.

BioWavePass wants to make that transition easier for our strategic partners.

Build the MVP. Test at scale. Validate the solution. Prepare for commercial deployment.

For partners developing the next generation of palm vein technology applications, BioWavePass is ready to scale with you.

Learn more from: https://biowavepass.com/